Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Life Sciences - December, 2004
24 articles
- Appeals Court Rejects Challenge To Alpharma's 180-Day Exclusivity For Pfizer's Neurontin
- Pfizer Loses Trademark Suit Over Envacar In China
- USPTO Grants Reissuance Of Lovenox Patent
- Gibbons, Del Deo Targets Corporate Counsel As IP Group Expands
- Judge Reverses Last Remaining Aspect Of $7.1M Judgment Vs. Umbilical-Cord Blood Banks
- FDA Approves Teva's Generic OxyContin
- Canada Plans Sweeping Reforms Of Drug Patent Laws
- Thermage Expands Patent Suit Vs. Syneron Over Wrinkle Treatment
- India Vows To Revamp Patent Law By End Of Month
- USPTO To Reexamine Lipitor Patent
- Glaxo, Merck Mull Cross-Licensing Patents For Cervical Cancer Vaccines
- Chiron Sues Corus Pharma For Stealing Trade Secrets
- McAndrews, Held & Malloy Expands With Six New Attorneys
- D.C. Circuit Rejects Mylan's Bid To Make Generic Duragesic
- Judge Deals Blow To Boston Scientific In Medinol's Patent, Trade-Secret Suit
- Shire Faces Another Challenge To Patent For Adderall XR
- Barr Joins Challenge To Zyprexa Patent
- U.S. Warns Of Legal Action Against Australian Drug Laws
- U.S.-Israeli Talks Over Pharmaceutical Intellectual Property Regime Break Down
- Judge OKs Glaxo's $75M Settlement Over Alleged Relafen Evergreening
- Judge Seen Setting Timetable For Plavix Patent Trial Next Week
- Ranbaxy Launches Generic Clarithromycin After Defeating Abbott In U.K. Court
- Biosite Countersues Roche In Dispute Over Diagnostic Test Patents
- Brazil Threatens To Break Patents On AIDS/HIV Drugs